Synthesis and mechanism-of-action of a novel synthetic antibiotic based on a dendritic system with bow-tie topology

Over the course of the last decades, the continuous exposure of bacteria to antibiotics—at least in parts due to misprescription, misuse, and misdosing—has led to the widespread development of antimicrobial resistances. This development poses a threat to the available medication in losing their effectiveness in treating bacterial infections. On the drug development side, only minor advances have been made to bring forward novel therapeutics. In addition to increasing the efforts and approaches of tapping the natural sources of new antibiotics, synthetic approaches to developing novel antimicrobials are being pursued. In this study, BDTL049 was rationally designed using knowledge based on the properties of natural antibiotics. BDTL049 is a carbosilane dendritic system with bow-tie type topology, which has antimicrobial activity at concentrations comparable to clinically established natural antibiotics. In this report, we describe its mechanism of action on the Gram-positive model organism Bacillus subtilis. Exposure to BDTL049 resulted in a complex transcriptional response, which pointed toward disturbance of the cell envelope homeostasis accompanied by disruption of other central cellular processes of bacterial metabolism as the primary targets of BDTL049 treatment. By applying a combination of whole-cell biosensors, molecular staining, and voltage sensitive dyes, we demonstrate that the mode of action of BDTL049 comprises membrane depolarization concomitant with pore formation. As a result, this new molecule kills Gram-positive bacteria within minutes. Since BDTL049 attacks bacterial cells at different targets simultaneously, this might decrease the chances for the development of bacterial resistances, thereby making it a promising candidate for a future antimicrobial agent.

[1]  T. Mascher,et al.  Silver (I) N-Heterocyclic Carbenes Carbosilane Dendritic Systems and Their Imidazolium-Terminated Analogues as Antibacterial Agents: Study of Their Mode of Action , 2020, Pharmaceutics.

[2]  T. Mascher,et al.  Amphotericin B Specifically Induces the Two-Component System LnrJK: Development of a Novel Whole-Cell Biosensor for the Detection of Amphotericin-Like Polyenes , 2020, Frontiers in Microbiology.

[3]  P. Gabant,et al.  In the Age of Synthetic Biology, Will Antimicrobial Peptides be the Next Generation of Antibiotics? , 2020, Antibiotics.

[4]  F. González-Nilo,et al.  CATIONIC CARBOSILANE DENDRITC SYSTEMS AS PROMISING ANTI-AMYLOID AGENTS IN TYPE 2 DIABETES. , 2020, Chemistry.

[5]  T. Mascher,et al.  The Epipeptide YydF Intrinsically Triggers the Cell Envelope Stress Response of Bacillus subtilis and Causes Severe Membrane Perturbations , 2020, Frontiers in Microbiology.

[6]  T. Lu,et al.  Peptide Design Principles for Antimicrobial Applications. , 2019, Journal of molecular biology.

[7]  F. Albericio,et al.  Carbosilane Dendron-Peptide Nanoconjugates as Antimicrobial Agents. , 2019, Molecular pharmaceutics.

[8]  D. Britti,et al.  Antileishmanial Activity of Amphotericin B-loaded-PLGA Nanoparticles: An Overview , 2018, Materials.

[9]  M. Malý,et al.  Ammonium and guanidine carbosilane dendrimers and dendrons as microbicides , 2018 .

[10]  J. Errington,et al.  Lysozyme Counteracts β-Lactam Antibiotics by Promoting the Emergence of L-Form Bacteria , 2018, Cell.

[11]  J. Errington,et al.  Mode of Action and Heterologous Expression of the Natural Product Antibiotic Vancoresmycin. , 2017, ACS chemical biology.

[12]  Jörg Stülke,et al.  SubtiWiki in 2018: from genes and proteins to functional network annotation of the model organism Bacillus subtilis , 2017, Nucleic Acids Res..

[13]  T. Mascher,et al.  The Bacillus BioBrick Box 2.0: expanding the genetic toolbox for the standardized work with Bacillus subtilis , 2017, Scientific Reports.

[14]  T. G. Villa,et al.  Antimicrobial peptides (AMPs): Ancient compounds that represent novel weapons in the fight against bacteria. , 2017, Biochemical pharmacology.

[15]  T. Mascher,et al.  Membrane chaperoning by members of the PspA/IM30 protein family , 2017, Communicative & Integrative Biology.

[16]  H. Sahl,et al.  Daptomycin inhibits cell envelope synthesis by interfering with fluid membrane microdomains , 2016, Proceedings of the National Academy of Sciences.

[17]  Ellen M. Quardokus,et al.  MicrobeJ, a tool for high throughput bacterial cell detection and quantitative analysis , 2016, Nature Microbiology.

[18]  Georg Fritz,et al.  Anatomy of the bacitracin resistance network in Bacillus subtilis , 2016, Molecular microbiology.

[19]  L. Hamoen,et al.  Analysis of Antimicrobial-Triggered Membrane Depolarization Using Voltage Sensitive Dyes , 2016, Front. Cell Dev. Biol..

[20]  R. Gómez,et al.  Structure–activity relationship study of cationic carbosilane dendritic systems as antibacterial agents , 2016 .

[21]  T. Mascher,et al.  Cannibalism stress response in Bacillus subtilis. , 2016, Microbiology.

[22]  Marc Mendelson,et al.  The World Health Organization Global Action Plan for antimicrobial resistance. , 2015, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[23]  R. P. Ross,et al.  Lantibiotic Resistance , 2015, Microbiology and Molecular Reviews.

[24]  R. Gómez,et al.  Evaluation of the activity of new cationic carbosilane dendrimers on trophozoites and cysts of Acanthamoeba polyphaga , 2015, Parasitology Research.

[25]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[26]  Wei Shi,et al.  featureCounts: an efficient general purpose program for assigning sequence reads to genomic features , 2013, Bioinform..

[27]  Georg Fritz,et al.  The Bacillus BioBrick Box: generation and evaluation of essential genetic building blocks for standardized work with Bacillus subtilis , 2013, Journal of Biological Engineering.

[28]  M. Bramkamp,et al.  Flotillins functionally organize the bacterial membrane , 2013, Molecular microbiology.

[29]  R. Hamill Amphotericin B Formulations: A Comparative Review of Efficacy and Toxicity , 2013, Drugs.

[30]  M. Preobrazhenskaya,et al.  Structure-Antifungal Activity Relationships of Polyene Antibiotics of the Amphotericin B Group , 2013, Antimicrobial Agents and Chemotherapy.

[31]  T. Mascher,et al.  Cell Envelope Stress Response in Cell Wall-Deficient L-Forms of Bacillus subtilis , 2012, Antimicrobial Agents and Chemotherapy.

[32]  H. Sahl,et al.  Proteomic Response of Bacillus subtilis to Lantibiotics Reflects Differences in Interaction with the Cytoplasmic Membrane , 2012, Antimicrobial Agents and Chemotherapy.

[33]  Johannes E. Schindelin,et al.  Fiji: an open-source platform for biological-image analysis , 2012, Nature Methods.

[34]  Steven L Salzberg,et al.  Fast gapped-read alignment with Bowtie 2 , 2012, Nature Methods.

[35]  B. Schwikowski,et al.  Condition-Dependent Transcriptome Reveals High-Level Regulatory Architecture in Bacillus subtilis , 2012, Science.

[36]  J. Helmann,et al.  Analysis of the role of Bacillus subtilis σM in β‐lactam resistance reveals an essential role for c‐di‐AMP in peptidoglycan homeostasis , 2012, Molecular microbiology.

[37]  Gisbert Schneider,et al.  Designing antimicrobial peptides: form follows function , 2012, Nature Reviews Drug Discovery.

[38]  T. Mascher,et al.  Antibiotic research in the age of omics: from expression profiles to interspecies communication. , 2011, The Journal of antimicrobial chemotherapy.

[39]  Thorsten Mascher,et al.  Peptide Antibiotic Sensing and Detoxification Modules of Bacillus subtilis , 2010, Antimicrobial Agents and Chemotherapy.

[40]  Janine Kirstein,et al.  In-Depth Profiling of the LiaR Response of Bacillus subtilis , 2010, Journal of bacteriology.

[41]  R. H. Baltz Renaissance in antibacterial discovery from actinomycetes. , 2008, Current opinion in pharmacology.

[42]  N. Brunner,et al.  How many modes of action should an antibiotic have? , 2008, Current opinion in pharmacology.

[43]  D. Rai,et al.  Engineered synthesis of 7-oxo- and 15-deoxy-15-oxo-amphotericins: insights into structure-activity relationships in polyene antibiotics. , 2008, Chemistry and Biology.

[44]  Amitabha Chattopadhyay,et al.  The gramicidin ion channel: a model membrane protein. , 2007, Biochimica et biophysica acta.

[45]  Christoph Freiberg,et al.  Novel Whole-Cell Antibiotic Biosensors for Compound Discovery , 2007, Applied and Environmental Microbiology.

[46]  Thorsten Mascher,et al.  Regulation of LiaRS-Dependent Gene Expression in Bacillus subtilis: Identification of Inhibitor Proteins, Regulator Binding Sites, and Target Genes of a Conserved Cell Envelope Stress-Sensing Two-Component System , 2006, Journal of bacteriology.

[47]  M. Sarvas,et al.  Cationic antimicrobial peptides elicit a complex stress response in Bacillus subtilis that involves ECF-type sigma factors and two-component signal transduction systems. , 2005, Microbiology.

[48]  Sara L. Zimmer,et al.  Antibiotic-Inducible Promoter Regulated by the Cell Envelope Stress-Sensing Two-Component System LiaRS of Bacillus subtilis , 2004, Antimicrobial Agents and Chemotherapy.

[49]  Christoph Schaab,et al.  Panel of Bacillus subtilis Reporter Strains Indicative of Various Modes of Action , 2004, Antimicrobial Agents and Chemotherapy.

[50]  R. Benz,et al.  Lipid II-Mediated Pore Formation by the Peptide Antibiotic Nisin: a Black Lipid Membrane Study , 2004, Journal of bacteriology.

[51]  Tao Wang,et al.  Cell wall stress responses in Bacillus subtilis: the regulatory network of the bacitracin stimulon , 2003, Molecular microbiology.

[52]  Alex E. Lash,et al.  Gene Expression Omnibus: NCBI gene expression and hybridization array data repository , 2002, Nucleic Acids Res..

[53]  Oscar P. Kuipers,et al.  Specific Binding of Nisin to the Peptidoglycan Precursor Lipid II Combines Pore Formation and Inhibition of Cell Wall Biosynthesis for Potent Antibiotic Activity* , 2001, The Journal of Biological Chemistry.

[54]  O. Kuipers,et al.  Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic. , 1999, Science.

[55]  Doris Ma Fat,et al.  WHO Library Cataloguing-in-Publication Data , 2001 .

[56]  D. Cheo,et al.  Cloning and characterization of DNA damage-inducible promoter regions from Bacillus subtilis , 1991, Journal of bacteriology.

[57]  C. Anagnostopoulos,et al.  REQUIREMENTS FOR TRANSFORMATION IN BACILLUS SUBTILIS , 1961, Journal of bacteriology.